What are the indications, dosage, and contraindications for chloramphenicol capsules?

INDICATION OF CAP CHLORPHENICOL AND DOSAGE AND CONTRAINDICATION

Indications

Chloramphenicol capsules should be reserved exclusively for serious infections where less dangerous antibiotics are ineffective or contraindicated, never for trivial infections. 1

The FDA-approved indications include:

• Acute typhoid fever (Salmonella typhi) - not for carrier state 1
• Serious susceptible infections:
  • Salmonella species
  • H. influenzae (especially meningeal infections)
  • Rickettsia
  • Lymphogranuloma-psittacosis group
  • Gram-negative bacteremia or meningitis
  • Organisms resistant to all other appropriate antimicrobials 1
• Cystic fibrosis regimens 1

In clinical guidelines, chloramphenicol serves as an alternative agent for bacterial meningitis when third-generation cephalosporins cannot be used, dosed at 25 mg/kg every 6 hours in adults 2. It is particularly valuable because it achieves excellent CNS penetration and is bactericidal against the three major meningeal pathogens: H. influenzae, S. pneumoniae, and N. meningitidis 3, 4.

Dosage

Adults

• Standard dose: 50 mg/kg/day divided into 4 doses every 6 hours 1
• Severe infections: May increase up to 100 mg/kg/day, but reduce to 50 mg/kg/day as soon as possible 1
• Maximum practical dose: Most clinicians consider 8-9 g/day as the upper limit 5
• Meningitis dosing (guideline): 4-6 g/day (approximately 25 mg/kg every 6 hours) 6, 2

Pediatric Patients

• Standard dose: 50 mg/kg/day divided into 4 doses every 6 hours 1
• Severe infections: Up to 75-100 mg/kg/day for meningitis or bacteremia, reduce to 50 mg/kg/day when possible 6, 1

Neonates (Critical Population)

• First 2 weeks of life: 25 mg/kg/day in 4 divided doses every 6 hours 1
• After 2 weeks (full-term): Up to 50 mg/kg/day in 4 divided doses 1
• Premature infants: Maintain 25 mg/kg/day due to immature hepatic/renal function 1

Critical caveat: Neonates require dose reduction and therapeutic drug monitoring because immature liver and kidney function leads to drug accumulation and risk of gray baby syndrome 1.

Patients with Hepatic or Renal Impairment

Dosage must be reduced and blood concentrations monitored, as these patients cannot adequately metabolize or excrete the drug 1.

Contraindications

Absolute contraindications:

• Previous hypersensitivity or toxic reaction to chloramphenicol 1
• Trivial infections (colds, influenza, throat infections) 1
• Prophylactic use to prevent bacterial infections 1

Relative contraindications (extreme caution required):

• Conditions where bone marrow suppression would be catastrophic
• Inability to monitor blood counts or drug levels when indicated

Critical Safety Considerations

The major toxicity concern is aplastic anemia, occurring in approximately 1 in 24,500-40,800 treatment courses, which can be fatal 3. This idiosyncratic reaction can occur after either oral or parenteral administration and is unpredictable 3, 4.

Reversible bone marrow suppression is dose-related and common, requiring serial monitoring of reticulocyte and complete blood counts during therapy 3.

Gray baby syndrome in neonates is preventable through appropriate dose reduction and therapeutic drug monitoring 1, 3.

Common pitfall: Using chloramphenicol for minor infections or as first-line therapy when safer alternatives exist. The drug's unique properties (excellent tissue penetration, bactericidal activity against meningeal pathogens) make it invaluable for specific serious infections, but its toxicity profile demands judicious use 1, 5.